In consultation: Guidance and quality standards
Showing 1 to 5 of 5
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Violence and aggression: prevention and management | Draft scope consultation | NICE guideline | |
Nivolumab with ipilimumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency [ID1136] | Draft guidance | Technology appraisal guidance | |
Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma [ID2725] | Draft guidance | Technology appraisal guidance | |
Early and locally advanced breast cancer: diagnosis and management - Neoadjuvant chemotherapy and ovarian function suppression (update) | Draft guidance consultation | NICE guideline | |
Tarlatamab for previously treated advanced small-cell lung cancer [ID6364] | Draft guidance | Technology appraisal guidance |